Bioinformatics is more than running packages
Thinking about the algorithms in packages before running the code
With the development of the NGS field , now there are tons of
bioinformatics packages available for data analysis. There are a lot
package choices for each step of the NGS analysis. For example, tons of
short sequence alignment algorithms have been developed to meet the
requireme...
Click to read more ...
Covid19 seq approches
Covid19 seq approches
Click to read more ...
Finding needle in the hay
Signal and Noise
When I took the biostatistical course given by Dr. Thomas Love a few
years ago, he recommended us reading a seemingly unrelavent stastical
book “ The signal and the noise” by Nate Silver. The book is great and
uncovers the promises and pitfalls of the big data analysis, one of the
biggest pitfalls is that in most times what we...
Click to read more ...
Coming Therapies
Coming Therapies
John Carroll at Endpoint recently selected 11 potential companies for near future “The Endpoints 11: A group of disruptive upstarts on a do-or-die mission to launch new meds”. Including Arrakis that I previously mentioned, Moderna’s potent rival BioNTech, see full list below.
Arrakis Therapeutics
Autolus
BioNTech
Cod...
Click to read more ...
mRNA Therapy
Witness of a new era
Moderna annouced their pre-clinical data entitled “Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia”. They showed positive results for methylmalonic acidemia/aciduria (MMA) murine models by treating with codon-optimized human methylmalonyl-CoA mutase (hMUT) mRNA. This, however is not even counted as ...
Click to read more ...